Famciclovir
Pricing Report NDC 0781-5620-31

View Wholesale Price per Unit, Acquisition Costs, and Historic Pricing Trends
Table of Contents
  1. Current Pricing Information
  2. Pricing History

Current Package Pricing Information

This product is EXCLUDED from the official NDC directory because the listing data was discontinued by the firm.

The latest wholesale acquisition cost for Famciclovir (NDC 0781-5620-31) is $1.02241 per EA. This benchmark price is based on the National Average Drug Acquisition Cost (NADAC) and has been effective since Nov 19, 2014.

As a provided by Sandoz Inc, this medication is distributed in a 30 TABLET, FILM COATED in 1 BOTTLE configuration. The pricing data is derived from C/I - Chain or Independent Pharmacy surveys, reflecting the actual invoice prices paid by community pharmacies to drug wholesalers.

NADAC Pricing Summary

NADAC pricing snapshot for this package NDC

Acquisition Cost
$1.02241
Per EA

Pricing Unit
Per EA Pricing Unit
Indicates the billing unit (ML, GM or EA).
Effective Date
Nov 19, 2014
Billable Units
30 EA
Estimated Package Price
$30.67
Data Status
As of Feb 11, 2015
Pharmacy Source Pharmacy Type Indicator
Data collected from Chain/Independent pharmacy surveys.
C/I - Chain or Independent Pharmacy
Rate Classification Classification for Rate Setting
Indicates if the NDC is Brand (B) or Generic (G).
G - Generic
Package NDC
0781-5620-31
Description
30 TABLET, FILM COATED in 1 BOTTLE
Pricing Methodology Explanation
The NADAC was carried forward from the previous file.
The CMS Covered Outpatient File drug category type of S/I/N (Single Source/Innovator/Non-Innovator) has not been applied. Most S/I drugs with the same strength, dosage form and route of administration were grouped together for the purpose of the NADAC calculation and N drugs were also grouped together. In some cases, however, in calculating a NADAC, the CMS S/I/N designation was not applied when the state Medicaid brand or generic payment practices for these drugs generally differed from the CMS Covered Outpatient File designation.

Historical Pricing Trends & Acquisition Cost Benchmarks

Since Nov 2013, the NADAC wholesale price for (NDC ) has moved within a range of $0.70552 to $1.15293 per EA. Over this 11 months period, the pricing trend reflects the shifting acquisition costs reported by retail and chain pharmacies to the Centers for Medicare and Medicaid Services (CMS). The following interactive chart and historical table detail every recorded price adjustment based on these federal surveys.

Price Range
$0.7055 - $1.1529
Market Volatility
63.42% Variance
Latest Trend
1.00%
Date Unit Price Unit Source Method Rate
Nov 19, 2014 $1.02241 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
Nov 19, 2014 $1.02241 EAC/I - Chain or Independent PharmacyCode 4, 6G - Generic
Aug 20, 2014 $1.03271 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
Aug 20, 2014 $1.03271 EAC/I - Chain or Independent PharmacyCode 4, 6G - Generic
Jul 23, 2014 $0.95708 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
May 21, 2014 $0.98863 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
May 21, 2014 $0.98863 EAC/I - Chain or Independent PharmacyCode 4, 6G - Generic
Apr 23, 2014 $0.91167 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
Mar 19, 2014 $0.88262 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
Feb 19, 2014 $0.79256 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
Jan 22, 2014 $1.15293 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
Dec 18, 2013 $0.81414 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
Nov 21, 2013 $0.70552 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic

Pricing Methodology Legend

  • Code 1: The NADAC was calculated using information from the most recently completed pharmacy survey.
  • Code 4: The NADAC was carried forward from the previous file.
  • Code 6: The CMS Covered Outpatient File drug category type of S/I/N (Single Source/Innovator/Non-Innovator) has not been applied. Most S/I drugs with the same strength, dosage form and route of administration were grouped together for the purpose of the NADAC calculation and N drugs were also grouped together. In some cases, however, in calculating a NADAC, the CMS S/I/N designation was not applied when the state Medicaid brand or generic payment practices for these drugs generally differed from the CMS Covered Outpatient File designation.

Understanding NADAC Pricing Data

The National Average Drug Acquisition Cost (NADAC) is compiled by the Centers for Medicare and Medicaid Services (CMS). This data is derived from random monthly surveys of more than 60,000 pharmacies across all 50 states.

Important Price Distinction:

The prices listed on this page represent the wholesale invoice price paid by pharmacies to acquire the drug. This is NOT the retail price paid by consumers at the pharmacy counter. Final patient costs typically include pharmacy markups, professional dispensing fees, and insurance adjustments.

NADAC Pricing Data Last Updated on: July 08, 2026